3-(ethylamino)-6-(1-methylimidazol-2-yl)sulfanyl-1,3-dihydroindol-2-one

C14H16N4OS — CID 43586901

IUPAC3-(ethylamino)-6-(1-methylimidazol-2-yl)sulfanyl-1,3-dihydroindol-2-one
SMILESCCNC1C(=O)Nc2cc(Sc3nccn3C)ccc21
InChIInChI=1S/C14H16N4OS/c1-3-15-12-10-5-4-9(8-11(10)17-13(12)19)20-14-16-6-7-18(14)2/h4-8,12,15H,3H2,1-2H3,(H,17,19)
InChIKeyITMZFWNTTFCXDW-UHFFFAOYSA-N
MW288.38 g/mol
LogP2.17
Rot. Bonds4

About 3-(ethylamino)-6-(1-methylimidazol-2-yl)sulfanyl-1,3-dihydroindol-2-one

3-(ethylamino)-6-(1-methylimidazol-2-yl)sulfanyl-1,3-dihydroindol-2-one (PubChem CID 43586901) has the molecular formula C14H16N4OS and a molecular weight of 288.38 g/mol. Its IUPAC name is 3-(ethylamino)-6-(1-methylimidazol-2-yl)sulfanyl-1,3-dihydroindol-2-one.

Molecular Properties

Compound Name3-(ethylamino)-6-(1-methylimidazol-2-yl)sulfanyl-1,3-dihydroindol-2-one
PubChem CID43586901
Molecular FormulaC14H16N4OS
Molecular Weight288.38 g/mol
Exact Mass288.10
IUPAC Name3-(ethylamino)-6-(1-methylimidazol-2-yl)sulfanyl-1,3-dihydroindol-2-one
SMILESCCNC1C(=O)Nc2cc(Sc3nccn3C)ccc21
InChIInChI=1S/C14H16N4OS/c1-3-15-12-10-5-4-9(8-11(10)17-13(12)19)20-14-16-6-7-18(14)2/h4-8,12,15H,3H2,1-2H3,(H,17,19)
InChIKeyITMZFWNTTFCXDW-UHFFFAOYSA-N
XLogP2.17
TPSA58.95 Ų
H-Bond Donors2
H-Bond Acceptors5
Rotatable Bonds4
Heavy Atoms20
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500288.38
LogP ≤ 52.17
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 105

Analyze 3-(ethylamino)-6-(1-methylimidazol-2-yl)sulfanyl-1,3-dihydroindol-2-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

N-butyl-4-(2,3-dihydroindol-1-yl)-3-imidazol-1-yl-4-oxobutanamide
CID 4319544
N-[3-(diethylamino)propyl]-4-(2,3-dihydro-1H-indol-1-yl)-3-(1H-imidazol-1-yl)-4-oxobutanamide
CID 3552689
N-[2-[butyl(methyl)amino]ethyl]-4-(2,3-dihydroindol-1-yl)-3-imidazol-1-yl-4-oxobutanamide
CID 3626948
N-butan-2-yl-4-(2,3-dihydroindol-1-yl)-3-imidazol-1-yl-4-oxobutanamide
CID 4083767
2-[4-(2,3-dihydroindol-1-ylsulfonyl)imidazol-1-yl]-N-(3-methylsulfanylphenyl)acetamide
CID 20949947
5-Fluoro-3-(3-imidazol-1-ylpropylamino)-1,3-dihydroindol-2-one
CID 43126733
6-Fluoro-3-(3-imidazol-1-ylpropylamino)-1,3-dihydroindol-2-one
CID 43126752
5-Fluoro-3-(1-imidazol-1-ylpropan-2-ylamino)-1,3-dihydroindol-2-one
CID 43749692
6-Fluoro-3-(1-imidazol-1-ylpropan-2-ylamino)-1,3-dihydroindol-2-one
CID 43749782
5-fluoro-6-(1-methylimidazol-2-yl)sulfanyl-1H-indole-2,3-dione
CID 80758662
5-fluoro-6-(1H-imidazol-2-ylsulfanyl)-1H-indole-2,3-dione
CID 107780514
4-(2,3-dihydro-1H-indol-1-yl)-N-heptyl-3-(1H-imidazol-1-yl)-4-oxobutanamide
CID 5052591

Frequently Asked Questions

What is the IUPAC name of 3-(ethylamino)-6-(1-methylimidazol-2-yl)sulfanyl-1,3-dihydroindol-2-one?
The IUPAC name of 3-(ethylamino)-6-(1-methylimidazol-2-yl)sulfanyl-1,3-dihydroindol-2-one (CID 43586901) is 3-(ethylamino)-6-(1-methylimidazol-2-yl)sulfanyl-1,3-dihydroindol-2-one.
What is the SMILES notation for 3-(ethylamino)-6-(1-methylimidazol-2-yl)sulfanyl-1,3-dihydroindol-2-one?
The canonical SMILES for 3-(ethylamino)-6-(1-methylimidazol-2-yl)sulfanyl-1,3-dihydroindol-2-one is CCNC1C(=O)Nc2cc(Sc3nccn3C)ccc21.
What is the InChIKey of 3-(ethylamino)-6-(1-methylimidazol-2-yl)sulfanyl-1,3-dihydroindol-2-one?
The InChIKey is ITMZFWNTTFCXDW-UHFFFAOYSA-N. The full InChI is InChI=1S/C14H16N4OS/c1-3-15-12-10-5-4-9(8-11(10)17-13(12)19)20-14-16-6-7-18(14)2/h4-8,12,15H,3H2,1-2H3,(H,17,19).
What are the key properties of 3-(ethylamino)-6-(1-methylimidazol-2-yl)sulfanyl-1,3-dihydroindol-2-one?
3-(ethylamino)-6-(1-methylimidazol-2-yl)sulfanyl-1,3-dihydroindol-2-one has a molecular weight of 288.38 g/mol, XLogP of 2.17, 4 rotatable bonds, 2 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for 3-(ethylamino)-6-(1-methylimidazol-2-yl)sulfanyl-1,3-dihydroindol-2-one is sourced from PubChem (CID 43586901), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).